Free Trial

Bolt Biotherapeutics (BOLT) Institutional Ownership

Bolt Biotherapeutics logo
$4.67 +0.08 (+1.74%)
Closing price 04:00 PM Eastern
Extended Trading
$4.76 +0.09 (+1.93%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Bolt Biotherapeutics (NASDAQ:BOLT)

Current
Institutional Ownership
Percentage
86.70%
Number of
Institutional Buyers
(last 12 months)
6
Total
Institutional Inflows
(last 12 months)
$650.86K
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$50.80M
Get BOLT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bolt Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

BOLT Institutional Buying and Selling by Quarter

Bolt Biotherapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/13/2026Vivo Capital LLC72,414$396K0.0%-58.9%3.772%
2/12/2026Renaissance Technologies LLC55,025$301K0.0%+92.2%2.866%
2/11/2026 T3 Companies LLC38,000$208K0.3%N/A1.979%
2/6/2026Nano Cap New Millennium Growth Fund L P20,500$112K0.1%N/A1.068%
11/17/2025Susquehanna International Group LLP16,642$89K0.0%N/A0.867%
11/14/2025Shay Capital LLC15,958$85K0.0%N/A0.831%
11/14/2025Squarepoint Ops LLC14,836$79K0.0%+19.8%0.773%
8/15/2025Sofinnova Investments Inc.137,721$795K0.0%-95.0%7.173%
8/14/2025Vivo Capital LLC176,064$986K0.1%-95.0%9.170%
8/14/2025Nan Fung Group Holdings Ltd58,347$337K0.5%-95.0%3.039%
8/11/2025Pfizer Inc31,305$181K0.0%-95.0%1.630%
8/8/2025Geode Capital Management LLC18,533$108K0.0%-95.1%0.965%
7/31/2025 Board of Trustees of The Leland Stanford Junior University35,978$208K0.0%-95.0%1.874%
2/17/2025Velan Capital Investment Management LP50,000$27K0.0%N/A0.131%
2/17/2025Squarepoint Ops LLC48,971$26K0.0%N/A0.128%
2/17/2025Millennium Management LLC47,025$25K0.0%N/A0.123%
2/17/2025Citadel Advisors LLC78,961$42K0.0%N/A0.206%
11/16/2024Geode Capital Management LLC352,426$228K0.0%-5.0%0.921%
11/13/2024FMR LLC115,386$75K0.0%+33.2%0.302%
8/9/2024Renaissance Technologies LLC276,739$208K0.0%-46.5%0.726%
8/5/2024Acuitas Investments LLC630,507$473K0.3%+21.7%1.654%
7/18/2024Assenagon Asset Management S.A.34,488$26K0.0%N/A0.090%
2/15/2024Board of Trustees of The Leland Stanford Junior University719,546$806K0.1%-5.0%1.895%
2/7/2024Vivo Capital LLC3,521,291$3.94M0.3%-9.0%9.274%
11/14/2023Newtyn Management LLC1,020,000$1.06M0.3%+2.0%2.688%
7/26/2023Privium Fund Management B.V.116,516$148K0.0%N/A0.308%
7/25/2023Assenagon Asset Management S.A.158,289$203K0.0%-29.9%0.419%
5/8/2023Bailard Inc.28,500$40K0.0%N/A0.075%
2/15/2023Tang Capital Management LLC400,000$520K0.1%+100.0%1.062%
2/14/2023Susquehanna International Group LLP20,307$26K0.0%N/A0.054%
2/8/2023Russell Investments Group Ltd.40,195$52K0.0%-38.2%0.107%
1/12/2023Assenagon Asset Management S.A.225,816$294K0.0%-19.3%0.600%
1/12/2023Marquette Asset Management LLC97,835$127K0.0%+53.4%0.260%
11/15/2022Caas Capital Management LP116,777$173K0.0%N/A0.310%
11/14/2022RA Capital Management L.P.533,432$789K0.0%+18.5%1.417%
11/14/2022Ergoteles LLC88,174$130K0.0%-16.5%0.234%
11/4/2022Russell Investments Group Ltd.64,995$96K0.0%-32.4%0.173%
11/1/2022Privium Fund Management UK Ltd116,516$172K0.2%N/A0.310%
10/18/2022Bailard Inc.46,383$69K0.0%N/A0.123%
7/29/2022Russell Investments Group Ltd.96,100$196K0.0%N/A0.256%
7/27/2022Assenagon Asset Management S.A.275,552$562K0.0%N/A0.735%
7/15/2022Marquette Asset Management LLC63,779$130K0.0%N/A0.170%
5/16/2022Echo Street Capital Management LLC123,804$5.49M0.0%N/A0.330%
5/11/2022GSA Capital Partners LLP54,038$148K0.0%N/A0.144%
5/9/2022Qube Research & Technologies Ltd19,611$54K0.0%-57.0%0.052%
2/19/2022Woodline Partners LP403,357$1.98M0.0%+2.3%1.082%
2/14/2022Suvretta Capital Management LLC2,230,250$10.93M0.2%+68.3%5.982%
2/14/2022Eventide Asset Management LLC1,449,494$7.10M0.1%+171.4%3.888%
2/11/2022Ensign Peak Advisors Inc18,500$91K0.0%-36.0%0.050%
2/10/2022Qube Research & Technologies Ltd45,640$224K0.0%+204.2%0.122%
2/8/2022ProShare Advisors LLC10,249$50K0.0%N/A0.027%
2/8/2022Northern Trust Corp194,893$955K0.0%+4.3%0.523%
2/7/2022SG Americas Securities LLC10,490$51K0.0%-25.5%0.028%


BOLT Institutional Ownership - Frequently Asked Questions

During the previous two years, 18 institutional investors and hedge funds held shares of Bolt Biotherapeutics. The most heavily invested institutionals were Sofinnova Investments Inc. ($795K), Acuitas Investments LLC ($473K), Vivo Capital LLC ($396K), Nan Fung Group Holdings Ltd ($337K), Renaissance Technologies LLC ($301K), T3 Companies LLC ($208K), and Board of Trustees of The Leland Stanford Junior University ($208K).Learn more on Bolt Biotherapeutics' institutional investors.

86.70% of Bolt Biotherapeutics' stock is owned by institutional investors. Learn more on BOLT's institutional investor holdings.

Of the 12 institutional investors that purchased Bolt Biotherapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Acuitas Investments LLC ($112.56K), Citadel Advisors LLC ($78.96K), Squarepoint Ops LLC ($51.42K), Velan Capital Investment Management LP ($50K), Millennium Management LLC ($47.03K), T3 Companies LLC ($38K), and Assenagon Asset Management S.A. ($34.49K).

Institutional investors have bought a total of 119,948 shares in the last 24 months. This purchase volume represents approximately $650.86K in transactions.

The following institutional investors have sold Bolt Biotherapeutics stock in the last 24 months: Vivo Capital LLC ($3.45M), Sofinnova Investments Inc. ($2.62M), Nan Fung Group Holdings Ltd ($1.11M), Board of Trustees of The Leland Stanford Junior University ($683.57K), Pfizer Inc ($594.80K), and Geode Capital Management LLC ($356.58K).

Institutional investors have sold a total of 8,809,150 shares in the last 24 months. This volume of shares sold represents approximately $50.80M in transactions.



This page (NASDAQ:BOLT) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners